Status:
ENROLLING_BY_INVITATION
Clinical Trial to Evaluate the Efficacy and Safety of a Thoracic and Abdominal Endoscopic Surgical System
Lead Sponsor:
Cornerstone Robotics
Conditions:
Pathologic Stage I Gastric Cancer AJCC v8
Colorectal Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Evaluation of the efficacy and safety of thoracic and abdominal endoscopic surgical systems manufactured by Shenzhen Cornerstone Robotics Technology Co., Ltd. for use in general, gynaecological and th...
Detailed Description
The trial was designed using a prospective, multi-centre, single-group target value approach. For subjects who intend to undergo general surgery, gynaecological surgery and thoracic surgery assisted ...
Eligibility Criteria
Inclusion
- Age ≥ 18 and ≤ 80 years;
- Body Mass Height Index (BMI) 18\<BMI\<30kg/㎡;
- Patients identified by the investigator as suitable for general, gynaecological and thoracic surgery;
- Written informed consent.
Exclusion
- Need for emergency surgery (e.g. gastric cancer, colorectal cancer combined with perforation, bleeding, obstruction, etc.);
- With other malignancies or a previous history of other malignancies.
- Preoperative imaging suggests that the tumour has distant metastases.
- The patient has a history of relevant surgery or previous history of other malignancy and is judged by the investigator to be unsuitable for enrolment.
- Severe bleeding tendencies or coagulopathic disorders.
- With long-term use of anticoagulant and anti-platelet drugs (anti-platelet aggregation drugs discontinued less than 1 week prior to surgery), history of bleeding disorders or hematopoietic or coagulation disorders.
- Significant immunodeficiency due to underlying illness (e.g. HIV/AIDS) and/or medication (e.g. systemic corticosteroids).
- Women who are pregnant or nursing an infant.
- With severe allergies and suspected or established alcohol, drug or substance addiction.
- Other conditions which, in the opinion of the investigator, make participation in this trial inappropriate.
Key Trial Info
Start Date :
January 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 18 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06587152
Start Date
January 22 2024
End Date
February 18 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310000